NorthCoast Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

NorthCoast Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$28.9M	Sell	50,621 -4,845	-9%	-$2.66M	1.05%	22
2021 Q2	$28M	Buy	55,466 +30,282	+120%	+$14.3M	1%	24
2021 Q1	$11.5M	Buy	25,184 +17,681	+236%	+$8.44M	0.47%	61
2020 Q4	$3.5M	Buy	7,503 +126	+2%	+$59.1K	0.16%	105
2020 Q3	$3.26M	Buy	7,377 +7	+0.1%	+$2.89K	0.17%	100
2020 Q2	$2.67M	Sell	7,370 -54	-0.7%	-$18.1K	0.15%	98
2020 Q1	$2.1M	Buy	+7,424	New	+$2.34M	0.13%	98
2019 Q3	–	Sell	-7,048	Closed	-$2.07M	–	273
2019 Q2	$2.07M	Sell	7,048 -9,746	-58%	-$2.68M	0.13%	104
2019 Q1	$4.6M	Sell	16,794 -60	-0.4%	-$14.9K	0.3%	67
2018 Q4	$3.77M	Buy	+16,854	New	+$3.95M	0.29%	66
2015 Q2	–	Sell	-462,478	Closed	-$62.1M	–	172
2015 Q1	$62.1M	Sell	462,478 -24,992	-5%	-$3.22M	2.91%	12
2014 Q4	$61.1M	Buy	487,470 +19,782	+4%	+$2.41M	3%	17
2014 Q3	$56.9M	Buy	467,688 +8,642	+2%	+$1.05M	2.81%	15
2014 Q2	$54.2M	Buy	459,046 +450,610	+5,342%	+$53M	3.15%	10
2014 Q1	$1.01M	Buy	+8,436	New	+$1M	0.07%	124

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NorthCoast Asset Management's TMO Position: Q3 2021 in Review

NorthCoast Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 8.7% in Q3 2021, selling an estimated $2.66M and leaving 50,621 shares worth $28.9M. The position accounts for 1.05% of the portfolio, ranked #22.

NorthCoast Asset Management first reported a position in TMO in Q1 2014 and has held it in 15 quarters since. The position peaked at $62.1M in Q1 2015. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

NorthCoast Asset Management held 50,621 shares of Thermo Fisher Scientific worth $28.9M as of Q3 2021.
NorthCoast Asset Management sold 4,845 Thermo Fisher Scientific shares in Q3 2021, an estimated $2.66M.
Thermo Fisher Scientific made up 1.05% of NorthCoast Asset Management's portfolio in Q3 2021, its #22 holding.
NorthCoast Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 15 quarters since.
NorthCoast Asset Management's Thermo Fisher Scientific position peaked at $62.1M in Q1 2015.
2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.